Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein

Abstract

This FPL1 recombinant represents an appropriate immunogen for expression of HPV-L1 in human cells. The final aim is to develop a safe, immunogenic, and less expensive prophylactic vaccine against HPV.